Stereotaxis (STXS) director Benfer reports 46,948-share RSU grant
Rhea-AI Filing Summary
Stereotaxis, Inc. director David Benfer reported an equity award of 46,948 shares of common stock on 01/02/2026. These were granted as restricted share units, each representing the right to receive one share of common stock at a price of $0 per share.
The restricted share units vest on the earliest of the fifth anniversary of the award date, the date his board service ends, or a Change of Control as defined in the award documents. After this grant, Benfer beneficially owns 515,872 shares directly, 2,700 shares indirectly through his spouse, and 210,255 shares indirectly through the Benfer Family Trust.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Stereotaxis (STXS) report for David Benfer?
The report shows that director David Benfer acquired 46,948 shares of common stock of Stereotaxis, Inc. on 01/02/2026 through a grant of restricted share units.
What type of shares did David Benfer receive in the latest Stereotaxis (STXS) filing?
He received restricted share units, with each unit representing the right to receive one share of Stereotaxis common stock at a price of $0.
How do the restricted share units granted to David Benfer vest at Stereotaxis (STXS)?
The restricted share units vest on the earliest of five years from the award date, the date his service on the board ends, or a Change of Control as defined in the award documents.
How many Stereotaxis (STXS) shares does David Benfer beneficially own after this transaction?
After the transaction, he beneficially owns 515,872 shares directly, 2,700 shares indirectly through his spouse, and 210,255 shares indirectly through the Benfer Family Trust.
What is David Benfer’s relationship to Stereotaxis (STXS)?
David Benfer is reported as a director of Stereotaxis, Inc. in the filing.
Was the Stereotaxis (STXS) Form 4 filed for one or multiple reporting persons?
The Form 4 was filed by one reporting person, identified as David Benfer.